Studies have demonstrated a decreased expression and/or DNA binding activities of MafA and PDX-1 in diabetes and chronic hyperglycemia which present a gradual deterioration of pancreatic β-cell function [47]. The gene discussed is MAFA; the disease is diabetes mellitus.